Filing Details

Accession Number:
0001209191-21-055224
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-08 19:56:03
Reporting Period:
2021-09-03
Accepted Time:
2021-09-08 19:56:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187716 D Ph Lake Mary Polan 9975 Summers Ridge Road
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-03 5,867 $141.69 19,987 No 4 S Direct
Common Stock Disposition 2021-09-03 300 $142.06 19,687 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The weighted average sale price for these transactions was $141.69 per share, with a range of $140.99 to $141.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder the full information regarding the number of shares sold at each separate price.
  2. The weighted average sale price for these transactions was $142.06 per share, with a range of $142.03 to $142.08. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder the full information regarding the number of shares sold at each separate price.